Navigation Links
Cornerstone Therapeutics Inc. Stockholders Seeking More Money Regarding the Proposed Buyout by Chiesi Farmaceutici S.P.A. Encouraged to Contact Lawyers at Deans & Lyons
Date:10/19/2013

DALLAS, Oct. 18, 2013 /PRNewswire/ -- Securities lawyers at Deans & Lyons announced a class action against the board of Cornerstone Therapeutics Inc. (NASDAQ: CRTX) in connection with a buyout for $9.50 per share. Concerned CRTX investors should contact attorney Hamilton Lindley at 877-819-8033 or hlindley@deanslyons.com about their rights and remedies.

"Chiesi Farmaceutici has been a controlling shareholder since 2009 and currently owns 58% of Cornerstone stock. Yahoo! Finance has valued Cornerstone above the deal price consistently for the past month," said securities lawyer Hamilton Lindley. "Our potential shareholder lawsuit will seek to ensure that all relevant information is disclosed and that the Cornerstone Therapeutics Inc. shareholders receive the highest price reasonably available for their stock." 

Deans & Lyons has significant experience representing shareholders in securities lawsuits nationwide.  CRTX stockholders – or anyone with knowledge about this situation – should contact lawyer Hamilton Lindley at hlindley@deanslyons.com or 877-819-8033 with questions or concerns.

Hamilton Lindley
DEANS & LYONS LLP
325 North Saint Paul Street, Suite 1500
Dallas, TX 75201
Phone: 214-736-7861
Fax: 214-965-8505
Toll-free: 877-819-8033
hlindley@deanslyons.com
www.deanslyons.com


'/>"/>
SOURCE Deans & Lyons, LLP
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Stipulation Of Dismissal Of Claims By Plaintiff Cornerstone Biopharma, Inc.
2. Mast Therapeutics To Present At The 12th Annual BIO Investor Forum On October 8
3. Mast Therapeutics To Present At The Leerink Swann Rare Disease Roundtable On October 2
4. Aratana Therapeutics to Present at BioCenturys NewsMakers in the Biotech Industry Conference
5. Healthpoint Biotherapeutics To Assume Smith & Nephew Name
6. PTC Therapeutics to Present at World Muscle Society Congress
7. MabVax Therapeutics Receives $1,750,000 Small Business Innovation Research Contract Award From The National Cancer Institute To Support Development of Novel Pancreatic Cancer Diagnostic Imaging Agent
8. Chrysalis BioTherapeutics, Inc., Receives $1.5m from the National Cancer Institute to Mitigate Radiotherapy-Induced Brain Tissue Damage
9. Halozyme Therapeutics To Present At The BioCentury Newsmakers In The Biotech Industry Conference
10. Cell Therapeutics Announces Closing of Sale of Convertible Preferred Stock
11. Obesity Therapeutics to 2019 - Safety Concerns Hinder Drug Performance Despite Large Market Opportunity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Calif. , June 24, 2016  Global ... a biopharmaceutical company developing novel therapeutics for the ... needs, today announced the closing of its previously ... common stock, at the public offering price of ... the offering were offered by GBT. GBT estimates ...
(Date:6/24/2016)... DUBLIN , June 24, 2016 ... and Markets has announced the addition of the ... their offering. ... products and provides an updated review, including its applications ... covering the total market, which includes three main industries: ...
(Date:6/24/2016)... -- The Academy of Managed Care Pharmacy (AMCP) today ... allow biopharmaceutical companies to more easily share health care ... coverage decisions, a move that addresses the growing need ... The recommendations address restrictions in the sharing of product ... a prohibition that hinders decision makers from accessing HCEI ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified personal trainer is ... a fitness app. The fitness app plans to fix the two major problems leading the ... one size fits all type program , They don’t eliminate all the reasons ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... ... ... of Bruton Memorial Library on June 21 due to a possible lice infestation, as reported ... head lice: the parasite’s ability to live away from a human host, and to infest ... in the event that lice have simply gotten out of control. , As lice are ...
(Date:6/25/2016)... ... 25, 2016 , ... First Choice Emergency Room , the largest network ... the Medical Director of its new Mesquite-Samuell Farm facility. , “We are pleased ... location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a method ... —Johnson is one of the first doctors to perform the treatment. Orthobiologics are ...
Breaking Medicine News(10 mins):